BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22611150)

  • 1. Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience.
    D'Souza A; Lacy M; Gertz M; Kumar S; Buadi F; Hayman S; Dingli D; Zeldenrust S; Kyle R; Ansell S; Inwards D; Johnston P; Micallef I; Porrata L; Litzow M; Gastineau D; Hogan W; Dispenzieri A
    Blood; 2012 Jul; 120(1):56-62. PubMed ID: 22611150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan.
    Kawajiri-Manako C; Sakaida E; Ohwada C; Miyamoto T; Azuma T; Taguchi J; Mori T; Hasegawa Y; Kondo T; Yujiri T; Yoshimitsu M; Imada K; Kurahashi S; Kahata K; Ichinohe T; Hirokawa M; Atsuta Y; Nakaseko C
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1180-1186. PubMed ID: 29409882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcomes of Autologous Stem Cell Transplantation in Patients with Newly Diagnosed POEMS Syndrome.
    Li AA; Gao XM; Zhao H; Shen KN; Zhang L; Cao XX; Li J
    Transplant Cell Ther; 2024 Feb; 30(2):207.e1-207.e7. PubMed ID: 37931801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.
    Cook G; Iacobelli S; van Biezen A; Ziagkos D; LeBlond V; Abraham J; McQuaker G; Schoenland S; Rambaldi A; Halaburda K; Rovira M; Sica S; Byrne J; Sanz RG; Nagler A; van de Donk NW; Sinisalo M; Cook M; Kröger N; De Witte T; Morris C; Garderet L
    Haematologica; 2017 Jan; 102(1):160-167. PubMed ID: 27634201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea.
    Kook HW; Jang JE; Min CK; Yoon DH; Kim K; Bang SM; Park Y; Lee JH; Yoon SS; Kim JS
    J Korean Med Sci; 2024 Jan; 39(2):e5. PubMed ID: 38225781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review.
    Arana C; Pérez de León JA; Gómez-Moreno G; Pérez-Cano R; Martín Hernández T
    Am J Case Rep; 2015 Mar; 16():124-9. PubMed ID: 25726020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation.
    Ishii Y; Yamazaki E; Ishiyama Y; Yamamoto E; Hattori Y; Hagihara M; Tomita N; Ishigatsubo Y
    Int J Hematol; 2013 Dec; 98(6):723-8. PubMed ID: 24166587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome.
    Karam C; Klein CJ; Dispenzieri A; Dyck PJ; Mandrekar J; D'Souza A; Mauermann ML
    Neurology; 2015 May; 84(19):1981-7. PubMed ID: 25878176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?
    Zhao H; Huang XF; Gao XM; Cai H; Zhang L; Feng J; Cao XX; Zhou DB; Li J
    Leukemia; 2019 Apr; 33(4):1023-1029. PubMed ID: 30700844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ixazomib Combined With Autologous Stem Cell Transplantation for POEMS Syndrome: A Case Report and Meta-Analysis.
    Ma J; Wang X; Lu H; Liang Z; Wang L
    Technol Cancer Res Treat; 2022; 21():15330338221123634. PubMed ID: 36579839
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.
    Miralles GD; O'Fallon JR; Talley NJ
    N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome.
    Ohwada C; Sakaida E; Kawajiri-Manako C; Nagao Y; Oshima-Hasegawa N; Togasaki E; Muto T; Tsukamoto S; Mitsukawa S; Takeda Y; Mimura N; Takeuchi M; Shimizu N; Misawa S; Iseki T; Kuwabara S; Nakaseko C
    Blood; 2018 May; 131(19):2173-2176. PubMed ID: 29599110
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome.
    Li J; Duan MH; Wang C; Huang XF; Zhang W; Cao XX; Zhu TN; Zhuang JL; Han B; Cai H; Cai HC; Zhou DB
    Leukemia; 2017 Jun; 31(6):1375-1381. PubMed ID: 28100909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [POEMS syndrome: advances in molecular pathophysiology and treatment].
    Nakaseko C
    Rinsho Ketsueki; 2019; 60(8):979-987. PubMed ID: 31484899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation.
    Rovira M; Carreras E; Bladé J; Graus F; Valls J; Fernández-Avilés F; Montserrat E
    Br J Haematol; 2001 Nov; 115(2):373-5. PubMed ID: 11703338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
    He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
    Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome.
    Jaccard A; Royer B; Bordessoule D; Brouet JC; Fermand JP
    Blood; 2002 Apr; 99(8):3057-9. PubMed ID: 11929800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
    Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
    Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment.
    Kourelis TV; Buadi FK; Gertz MA; Lacy MQ; Kumar SK; Kapoor P; Go RS; Lust JA; Hayman SR; Rajkumar V; Zeldenrust SR; Russell SJ; Dingli D; Lin Y; Leung N; Hwa YL; Gonsalves W; Kyle RA; Dispenzieri A
    Leukemia; 2016 May; 30(5):1079-85. PubMed ID: 26669974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of autologous peripheral blood stem cell transplantation (auto-PBSCT) on the neuropathic manifestations in POEMS syndrome].
    Gronier S; Delmont E; Legros L; Launay M; Jeandel PY; Fuzibet JG; Desnuelle C
    Rev Neurol (Paris); 2014 Jan; 170(1):37-45. PubMed ID: 24411685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.